Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» melanoma
melanoma
What’s next for Bristol Myers' relatlimab?
EP Vantage
Wed, 03/23/22 - 10:36 am
Bristol Myers Squibb
relatilimab
Opdivo
Opdualag
melanoma
Nektar Left Reassessing After Canceled Melanoma Trials
BioSpace
Tue, 03/15/22 - 11:38 pm
Nektar
Bristol Myers Squibb
clinical trials
melanoma
bempegaldesleukin
Idera Pharmaceuticals' stock tanks after AbbVie cuts enrollment early in a PhIb trial
Endpoints
Wed, 12/15/21 - 11:49 pm
Idera Pharmaceuticals
AbbVie
melanoma
clinical trials
tilsotolimod
Keytruda wins eighth FDA approval of 2021, moving into adjuvant and pediatric melanoma settings
Endpoints
Mon, 12/6/21 - 10:57 am
Merck
Keytruda
melanoma
adolescents
BioNTech Bags Fast-Track Status for Melanoma Treatment
BioSpace
Sat, 11/20/21 - 11:56 am
BioNTech
melanoma
BNT111
FDA
fast track
Proscia touts study showing digital pathology software detected melanoma
MedCity News
Thu, 10/14/21 - 11:10 pm
Proscia
diagnostics
melanoma
DermAI
artificial intelligence
BioNTech reports promising data on mRNA cocktail in mouse models of colon cancer and melanoma
Fierce Biotech
Wed, 09/8/21 - 11:24 pm
BioNTech
cancer
colon cancer
melanoma
MRNA
Merck's Keytruda takes home adjuvant win in melanoma, escalating early-line fight with Bristol Myers
Endpoints
Thu, 08/5/21 - 11:05 am
Keytruda
Merck
clinical trials
melanoma
BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma
Benzinga
Fri, 06/18/21 - 10:23 am
BioNTech
vaccines
MRNA
FixVac
melanoma
clinical trials
Getting under your skin: Sorrento leveraging novel drug delivery platform to treat melanoma in tie-up with Mayo Clinic
BioPharma Dive
Thu, 06/17/21 - 11:06 am
Sorrento Therapeutics
melanoma
R&D
Mayo Clinic
ASCO 2021 – Alkermes’s disappointment hones melanoma niche focus
EP Vantage
Fri, 06/4/21 - 10:41 am
ASCO 2021
Alkermes
melanoma
nemvaleukin alfa
At a Recent Cancer Research Conference, Instil Bio Stole the Show
Motley Fool
Thu, 04/29/21 - 10:30 am
Instil Bio
cancer
AACR
melanoma
Esmo 2020 – can Alkermes succeed where Nektar failed?
EP Vantage
Wed, 09/23/20 - 10:33 am
Alkermes
ESMO
ALKS 4230
melanoma
OnKure, Pfizer collaborate to evaluate combination of OKI-179 and binimetinib
Pharmaceutical Business Review
Tue, 09/22/20 - 11:06 am
OnKure
Pfizer
OKI-179
melanoma
Highlight Therapeutics trials second-line melanoma combo after immunotherapy fails
Pharmaforum
Wed, 09/2/20 - 10:49 am
Highlight Therapeutics
melanoma
BO-112
Keytruda
Merck
FDA approves Roche’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma
Pharmaceutical Business Review
Mon, 08/3/20 - 10:33 am
Roche
FDA
Tecentriq
Cotellic
Zelboraf
melanoma
Regeneron pairs with BioNTech on melanoma immunotherapy
Pharmaforum
Mon, 08/3/20 - 10:15 am
Regeneron
BioNTech
melanoma
Libtayo
vaccines
BNT111
MRNA
Roche’s Tecentriq claims melanoma OK, but don’t expect a sales surge
Pharmaforum
Fri, 07/31/20 - 10:43 am
Roche
Tecentriq
FDA
melanoma
Bristol-Myers Squibb
Merck
AACR: Roche's Tecentriq, added to Cotellic and Zelboraf, stalls melanoma progression
Fierce Pharma
Mon, 04/27/20 - 09:47 am
Roche
Tecentriq
Cotellic
Zelboraf
melanoma
AACR
Elios Therapeutics presents new Phase IIb data for personalized cancer vaccine in high-risk melanoma patients
Pharmaceutical Business Review
Mon, 02/10/20 - 11:35 pm
Elios Therapeutics
clinical trials
vaccines
melanoma
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »